Trials / Completed
CompletedNCT02109172
A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Cross-Over Study of QD and BID Nebulized TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Mylan Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluated the safety and efficacy of once and twice daily TD-4208 and placebo when administered using a jet nebulizer for 7 days in a cross-over design to patients with moderate to severe chronic obstructive pulmonary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TD-4208 | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-09-01
- Completion
- 2014-10-01
- First posted
- 2014-04-09
- Last updated
- 2022-02-24
- Results posted
- 2016-12-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02109172. Inclusion in this directory is not an endorsement.